PrEP: latest news

PrEP resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales and Scotland, PrEP is available through NHS sexual health clinics.It is also...

    From: Factsheets

    Information level Level 2
  • Pre-exposure prophylaxis (PrEP)

    PrEP is highly effective in preventing the sexual transmission of HIV. For PrEP to work well, it’s important to take the pills regularly.While PrEP can...

    From: Factsheets

    Information level Level 2
  • Using anti-HIV drugs to prevent HIV

    The goal of HIV treatment is an undetectable viral load. An undetectable viral load means that your blood has a level of HIV below the level which...

    From: Booklets

    Information level Level 2
  • PrEP

    This briefing paper provides an overview of pre-exposure prophylaxis (PrEP) for people planning, commissioning or providing HIV prevention activities in the UK. It does this by reviewing...

    From: HIV prevention briefing papers

  • Pre-exposure prophylaxis

    Pre-exposure prophylaxis is an experimental HIV-prevention strategy that would use antiretrovirals (ARVs) to protect HIV-negative people from HIV infection....

    From: Preventing HIV

    Information level Level 4

PrEP features

PrEP news from aidsmap

More news

PrEP news selected from other sources

  • Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

    Long-acting implants for PrEP are currently under development and mimic many aspects of contraceptive implants currently on the market (eg, Nexplanon and Jadelle). The PrEP implants are designed for placement under the skin, where the device resides and releases the ARV drug at a controlled rate over time.

    21 June 2018 | Contagion Live
  • New Zealand sees drop in people diagnosed with HIV

    The number of people diagnosed with HIV in New Zealand has significantly dropped, according to the AIDS Epidemiology Group of Otago University. It has been the first time the number has decreased since 2011. Last year, 197 people were diagnosed, a drop of 46 compared to 2016 when 243 people were diagnosed with HIV. Dr Sue McAllister said despite the drop being encouraging, it was too early to determine whether the decline would be maintained.

    20 June 2018 | 1 News Now

    The drug Truvada has the ability to reduce the risk of HIV transmission by more than 99%, but it's being withheld from the American public because of the greed of its manufacturer. Sign the petition to call on the National Institute of Health to break the patent around Truvada as PrEP.

    20 June 2018 |
  • Fairfax students to learn about HIV prevention pill in health classes

    The Fairfax County School Board voted last week to include information about pre-exposure prophylaxis — PrEP — in the district’s family life education curriculum, which includes lessons on sexual health and sexuality.

    19 June 2018 | Washington Post
  • Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis

    This draft guidance provides general nonclinical and clinical recommendations specific to the development of systemic drug products, with a focus on long-acting systemic drug products for the prevention of sexually acquired human immunodeficiency virus-1 (HIV-1) infection.

    18 June 2018 | US Food and Drug Administration
  • Zimbabwe launches 'HIV prevention' pill

    Government last week launched the pre-exposure prophylaxis strategy (PrEP), which is meant to reduce the risk of contracting HIV. Speaking at the "Million Men Circumcised" celebrations and launch of the PrEP Strategy in Harare on Friday, Minister of Health and Child Care Dr David Parirenyatwa said the oral PrEP was strictly for those who were at a higher risk of contracting HIV.

    18 June 2018 | Bulawayo 24 News
  • NHS England considers expanding PrEP trial - NAT comment

    Deborah Gold, Chief Executive of NAT (National AIDS Trust) said: “This proposed trial expansion, from 10,000 to 13,000 participants, is essential and we urge NHS England to confirm the decision urgently. This expansion was first proposed by NAT as necessary to estimate accurately the likely long-term needs of a routinely commissioned PrEP programme and it’s great news that this is now on the table.

    18 June 2018 | National AIDS Trust
  • Stigma may keep women from using HIV-prevention drugs

    Researchers found that many women feared being stigmatized if they used PrEP. About 37 percent believed they would be thought of as promiscuous, 32 percent thought people would believe they were HIV-positive and trying to disguise their status, and 14 percent thought other people would think they were “bad” people if they took the PrEP.

    15 June 2018 | Reuters
  • How to Deal With Conflicts About Ex-Lovers, HIV, Trump and More

    A provocative interview with author Sarah Schulman also reveals the most pressing issues facing gay people and the HIV community.

    13 June 2018 | Poz
  • ‘Last week I tested positive for HIV. My world imploded.’

    A gay man’s decision to announce his HIV diagnosis on Twitter has prompted an outpouring of support. Henry says he would have taken PrEP were it available: ‘I would have, and had asked my sexual health clinic about getting on the PrEP trials last year but there weren’t enough spaces.’

    12 June 2018 | Gay Star News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.